You are not facing a dire sentence—your prognosis is likely favorable with appropriate treatment.
Based on your presentation, you most likely have anti-RNP-positive myositis, which is a treatable condition with generally good outcomes, particularly given your young age, normal cardiac/renal/hepatic function, and absence of severe organ involvement 1.
Understanding Your Diagnosis
Your clinical picture strongly suggests anti-RNP-positive inflammatory myositis, not a worst-case scenario:
- High anti-RNP antibodies (86, normal <20) with speckled ANA pattern are the defining feature
- Proximal and distal muscle weakness (shoulders, hips, thighs, hands, legs) matches the typical presentation
- Joint pain (elbows, knees) occurs in 60% of anti-RNP patients—much more common than other myositis types 1
- Mildly elevated CK (527) is consistent; anti-RNP myositis often has less dramatic CK elevations than other forms
- Your demographic profile fits perfectly: anti-RNP myositis patients are typically younger (average ~37 years) and 60% are Black 1
Why This Is NOT the Worst Outcome
Key reassuring factors:
- No cancer association: Anti-RNP myositis does not carry the malignancy risk seen in dermatomyositis 1
- Zero mortality in the anti-RNP cohort during study follow-up 1
- Your organs are functioning well: Normal heart size, no pulmonary fluid, stable kidney function (creatinine 1.11-1.31 range is acceptable), normal liver enzymes
- You're young and otherwise healthy: This significantly improves treatment response and long-term outcomes
Expected EMG Findings
Your EMG on the scheduled date will likely show:
- Polyphasic motor unit potentials with short duration and low amplitude
- Increased insertional activity with fibrillation potentials and positive sharp waves
- Spontaneous activity suggesting active muscle membrane irritability 2
These findings are typical for inflammatory myopathy but are not specific—they confirm muscle involvement but don't distinguish between myositis subtypes.
Muscle Biopsy Considerations
You may need a muscle biopsy, particularly because:
- 4 of 7 anti-RNP patients in the key study had necrotizing muscle biopsies (showing muscle fiber death with minimal inflammation) 1
- Biopsy helps distinguish anti-RNP myositis from other conditions and guides treatment intensity
- MRI can guide biopsy site selection to target actively inflamed muscle 2
However, given your strongly positive anti-RNP antibodies, clinical presentation, and elevated CK, your rheumatologist may initiate treatment based on clinical diagnosis if EMG is confirmatory.
What You Can Expect
Natural history of anti-RNP myositis:
- Muscle weakness was the presenting feature in only 15% of patients, but 80% eventually develop it 1
- Arthritis occurs in 60% (you have this)
- Interstitial lung disease develops in 45% (your chest X-rays are currently normal, which is good)
- Pericarditis occurs in 40% but only in those with co-existing anti-Ro52 antibodies 1
Your upcoming cardiac stress test and 7-day monitor are appropriate screening measures, as cardiac involvement can occur but is typically manageable when detected early.
Treatment and Prognosis
You will likely receive:
- High-dose corticosteroids (prednisone) initially
- Steroid-sparing agent started concurrently (methotrexate, azathioprine, or mycophenolate mofetil) 2
- Physical therapy (which you're already doing—this is essential for maintaining muscle function)
Important caveat regarding G6PD deficiency: Your G6PD level of 41 (normal 100-376) means you must avoid certain medications that can trigger hemolysis. Inform your rheumatologist—this may affect choice of immunosuppressants. Avoid sulfa drugs, certain antimalarials, and high-dose vitamin C.
How Did This Happen?
This is NOT your fault:
- Not genetic in the traditional sense: While there may be genetic susceptibility, anti-RNP myositis is an acquired autoimmune condition
- Not from STDs: Your negative panels confirm this
- Not from moving South: Geographic location doesn't cause this condition
- Not preventable: There's no known lifestyle factor that causes anti-RNP myositis
The trigger is typically unknown, though viral infections can sometimes precede autoimmune myositis onset.
Common Pitfalls to Avoid
- Don't delay treatment: Early aggressive immunosuppression prevents irreversible muscle damage
- Don't stop medications prematurely: Relapses are common if treatment is discontinued too soon
- Monitor for interstitial lung disease: Even though your chest X-rays are normal, 45% develop ILD—you may need periodic pulmonary function tests and high-resolution CT
- Remember your G6PD deficiency: Always remind providers before starting new medications
Bottom Line
Your condition is serious but highly treatable, and you have every reason to expect a good outcome. The fact that you're being thoroughly evaluated (EMG, cardiac monitoring, rheumatology follow-up) means you're receiving appropriate care. Your normal organ function at baseline is a significant advantage. With proper immunosuppressive therapy and physical rehabilitation, most patients with anti-RNP myositis achieve good functional recovery.
You are not "screwed"—you have a manageable autoimmune condition that responds to treatment.